Howe & Rusling Inc. Sells 369 Shares of UnitedHealth Group Incorporated $UNH

Howe & Rusling Inc. cut its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 1.4% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 26,184 shares of the healthcare conglomerate’s stock after selling 369 shares during the period. UnitedHealth Group accounts for approximately 1.2% of Howe & Rusling Inc.’s portfolio, making the stock its 23rd biggest holding. Howe & Rusling Inc.’s holdings in UnitedHealth Group were worth $13,714,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Financial Management Professionals Inc. increased its stake in UnitedHealth Group by 0.8% during the first quarter. Financial Management Professionals Inc. now owns 2,224 shares of the healthcare conglomerate’s stock valued at $1,165,000 after acquiring an additional 17 shares during the period. Global Wealth Strategies & Associates increased its stake in UnitedHealth Group by 28.6% during the first quarter. Global Wealth Strategies & Associates now owns 90 shares of the healthcare conglomerate’s stock valued at $47,000 after acquiring an additional 20 shares during the period. Kolinsky Wealth Management LLC boosted its holdings in UnitedHealth Group by 1.0% during the fourth quarter. Kolinsky Wealth Management LLC now owns 2,135 shares of the healthcare conglomerate’s stock valued at $1,080,000 after purchasing an additional 21 shares in the last quarter. Retirement Planning Group LLC grew its stake in shares of UnitedHealth Group by 5.1% in the 1st quarter. Retirement Planning Group LLC now owns 430 shares of the healthcare conglomerate’s stock valued at $225,000 after purchasing an additional 21 shares during the period. Finally, Net Worth Advisory Group grew its stake in shares of UnitedHealth Group by 0.6% in the 1st quarter. Net Worth Advisory Group now owns 3,642 shares of the healthcare conglomerate’s stock valued at $1,907,000 after purchasing an additional 21 shares during the period. 87.86% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several equities research analysts have recently weighed in on UNH shares. JPMorgan Chase & Co. lowered their price objective on UnitedHealth Group from $418.00 to $310.00 and set an “overweight” rating on the stock in a research note on Wednesday, August 6th. TD Cowen downgraded UnitedHealth Group from a “buy” rating to a “hold” rating and set a $308.00 target price on the stock. in a report on Monday, May 19th. Barclays boosted their target price on UnitedHealth Group from $337.00 to $352.00 and gave the stock an “overweight” rating in a report on Thursday, September 4th. Hsbc Global Res downgraded UnitedHealth Group from a “hold” rating to a “moderate sell” rating in a report on Wednesday, May 21st. Finally, Oppenheimer reduced their price objective on UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating on the stock in a report on Wednesday, July 30th. Sixteen analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have issued a Sell rating to the company. According to data from MarketBeat.com, UnitedHealth Group currently has an average rating of “Moderate Buy” and a consensus price target of $355.77.

UnitedHealth Group Stock Performance

Shares of UnitedHealth Group stock opened at $353.89 on Friday. The firm has a fifty day moving average of $291.11 and a two-hundred day moving average of $370.48. The stock has a market capitalization of $320.51 billion, a price-to-earnings ratio of 15.33, a PEG ratio of 2.27 and a beta of 0.45. UnitedHealth Group Incorporated has a 52 week low of $234.60 and a 52 week high of $630.73. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing the consensus estimate of $4.45 by ($0.37). The business had revenue of $111.62 billion for the quarter, compared to the consensus estimate of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The business’s revenue was up 12.9% on a year-over-year basis. During the same quarter in the previous year, the firm posted $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, equities research analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 23rd. Investors of record on Monday, September 15th will be given a $2.21 dividend. The ex-dividend date is Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.5%. UnitedHealth Group’s dividend payout ratio is currently 38.30%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.